- Home
- GDYN vs LXRX Comparison
GDYN vs LXRX Comparison
Compare GDYN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | LXRX |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 592.8M | 547.4M |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GDYN | LXRX |
|---|---|---|
| Price | $6.46 | $1.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $11.00 | $3.23 |
| AVG Volume (30 Days) | 1.5M | ★ 3.0M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 350.00 | 21.25 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $111,283,000.00 | $31,081,000.00 |
| Revenue This Year | $19.77 | $56.61 |
| Revenue Next Year | $10.12 | N/A |
| P/E Ratio | $58.64 | ★ N/A |
| Revenue Growth | N/A | ★ 2481.48 |
| 52 Week Low | $6.11 | $0.28 |
| 52 Week High | $20.15 | $1.83 |
Technical Indicators
Market Signals| Indicator | GDYN | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.23 | 58.29 |
| Support Level | $6.16 | $1.07 |
| Resistance Level | $8.43 | $1.65 |
| Average True Range (ATR) | 0.45 | 0.10 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 18.15 | 73.33 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.